CCR5 and COVID-19: Maraviroc may reverse TEX and reduce cytokine storms.6 Moreover, dexamethasone, a drug for CCR5 gene (GeneCards GCID: GC03P046383), was reported to be able to reduce 28-day mortality for severe COVID-19.43 These findings illustrated that the cytokine–receptor axes may be important therapeutic targets.